300194 logo

Fuan Pharmaceutical (Group) Co., Ltd. Stock Price

SZSE:300194 Community·CN¥5.1b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

300194 Share Price Performance

CN¥0
-4.33 (-100.00%)
CN¥0
-4.33 (-100.00%)
Price CN¥0

300194 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Adequate balance sheet second-rate dividend payer.

1 Risk
1 Reward

Fuan Pharmaceutical (Group) Co., Ltd. Key Details

CN¥1.7b

Revenue

CN¥1.1b

Cost of Revenue

CN¥643.2m

Gross Profit

CN¥498.7m

Other Expenses

CN¥144.5m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
Apr 27, 2026
0.12
37.58%
8.44%
20.1%
View Full Analysis

About 300194

Founded
2004
Employees
3392
CEO
Lu Wang
WebsiteView website
www.fapharm.com

Fuan Pharmaceutical (Group) Co., Ltd., together with its subsidiaries, research and develops, produces, and sells chemical drugs in the People's Republic of China. It offers APIs; intermediates; and FFPs, such as anti-tumor, generic drugs, antibiotics and oral, as well as freeze-drying preparation for injection. The company was formerly known as Chongqing Fuan Pharmaceutical (Group) Co., Ltd. and changed its name to Fuan Pharmaceutical (Group) Co., Ltd. in August 2013. The company was founded in 2004 and is headquartered in Chongqing, the People's Republic of China.

Recent 300194 News & Updates

Recent updates

No updates